HerResolve™ in Detecting the Presence of Endometriosis Among Symptomatic Women

Sponsor
Chinese University of Hong Kong
Study ID
NCT07006987
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 49 Years
Healthy Volunteers
Accepted

Interventions

  • A non-invasive blood-based (HerResolve) — DEVICE
    A non-invasive blood-based test can detect endometriosis as compared to diagnostic laparoscopy

Study Details

Endometriosis (EMS) is a common gynecological disease that affects 176 million girls and women globally. EMS affects 5-10% of women and adolescents within the reproductive age range of 15-49 years, and for those facing infertility, this figure may climb up to 50%. EMS can start at the first menstrual period and last until menopause. Shockingly, between 50% and 80% of women grappling with pelvic pain are found to have EMS. The formation of scar tissue (adhesions, fibrosis) within the pelvis and other parts of the body can cause severe pain and lead to infertility.

Key Dates

First listed
Jun 5, 2025
Start date
Oct 14, 2025
Status verified
Dec 2025
Primary completion
May 31, 2030
Completion
Jun 1, 2037

Study Design

Enrollment
100 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: A non-invasive blood-based test
    A non-invasive blood-based test to detect endometriosis as compared to diagnostic laparoscopy

Primary Outcome Measure

Detecting endometriosis as compared to diagnostic laparoscopy [ Time Frame: 1 week ]

Central Contacts

Find similar trials

Nationwide
Endometriosis trialsWomen's health trialsFertility trials

Related Studies